Adverse Events of Special Interest, SLE Medication Utilization, Hospitalizations, and Organ Damage: Results from a Phase 4, Randomized, Double-Blind, Placebo-Controlled, 52-week Study of Belimumab in Adults with Active, Autoantibody-Positive SLESaira Sheikh,Morton Scheinberg,Cheng-Chung Wei,Dana Tegzova,William Stohl,Ricardo Acayaba de Toledo,Tamara Mucenic,Mauricio Abello Banfi,Kathleen Maksimowicz-McKinnon,Carlos Abud-Mendoza,Sandra Navarra,Mercedes Garcia,Ignacio Garcia-De La Torre,Josep Ordi Ros,Roger Abramino Levy,Damon L. Bass,Jorge Ross Terres,Raj Punwaney,Julia Harris,Alireza Nami,Amy Pierce,Kevin Thorneloe,Beulah Ji,David RothARTHRITIS & RHEUMATOLOGY（2019）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
